Notch receptors in GtoPdb v.2021.2

Authors

DOI:

https://doi.org/10.2218/gtopdb/F914/2021.2

Abstract

Aberrant Notch signalling is implicated in a number of human cancers [18, 26, 13, 21], and there is intense pharmaceutical activity being directed towards achieving clinically effective Notch pathway inhibition [7, 16].

Published

25-Jun-2021

How to Cite

Arumugam, T. V. and Sobey, C. (2021) “Notch receptors in GtoPdb v.2021.2”, IUPHAR/BPS Guide to Pharmacology CITE, 2021(2). doi: 10.2218/gtopdb/F914/2021.2.

Issue

Section

Summaries